R. O. Studer
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Antibiotic Resistance in Bacteria 6
- Pharmacology 16
- Microbial Natural Products and Biosynthesis 12
- Co-authors
- K. VoglerW. LergierOliver NaylerP. LanzDieter GillessenArnold TrzeciakP. QuittJohn Gatfield
- Journals
- Helvetica Chimica Acta (24 papers)Cellular and Molecular Life Sciences (8 papers)Molecular Pharmacology (2 papers)Journal of Biological Chemistry (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- SwitzerlandUnited StatesEstonia
In The Last Decade
R. O. Studer
70 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 121
- Molecular Medicine 85
- Pharmacology 161
- Molecular Biology 646
- Cellular and Molecular Neuroscience 143
- Microbiology 43
Countries citing papers authored by R. O. Studer
This map shows the geographic impact of R. O. Studer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. O. Studer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. O. Studer more than expected).
Fields of papers citing papers by R. O. Studer
This network shows the impact of papers produced by R. O. Studer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. O. Studer. The network helps show where R. O. Studer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R. O. Studer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2020 | 24 | |
| 3 | 2018 | 38 | |
| 4 | 2016 | 33 | |
| 5 | 2015 | 30 | |
| 6 | 2014 | 20 | |
| 7 | 2013 | 79 | |
| 8 | 2012 | 42 | |
| 9 | 2010 | 52 | |
| 10 | 2009 | 25 | |
| 11 | 2008 | 11 | |
| 12 | 2007 | 16 | |
| 13 | 2006 | 1 | |
| 14 | 2001 | 25 | |
| 15 | 1974 | 0 | |
| 16 | 1973 | 4 | |
| 17 | 1969 | 3 | |
| 18 | 1964 | 20 | |
| 19 | 1961 | 14 | |
| 20 | 1961 | 13 |
About R. O. Studer
R. O. Studer is a scholar working on Molecular Medicine, Pharmacology, Organic Chemistry, Molecular Biology and Pharmaceutical Science, having authored 72 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (20 papers), Microbial Natural Products and Biosynthesis (12 papers), Antibiotic Resistance in Bacteria (6 papers), Synthetic Organic Chemistry Methods (6 papers), Neuroendocrine regulation and behavior (6 papers), Synthesis and Catalytic Reactions (5 papers), Sphingolipid Metabolism and Signaling (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). The work is most often cited by research in Molecular Medicine (85 citations), Pharmacology (161 citations), Molecular Biology (646 citations), Cellular and Molecular Neuroscience (143 citations) and Microbiology (43 citations). R. O. Studer has collaborated with scholars based in Switzerland, United States and Estonia. Frequent co-authors include K. Vogler, W. Lergier, Oliver Nayler, P. Lanz, Dieter Gillessen, Arnold Trzeciak, P. Quitt, John Gatfield, Martine Clozel and Katalin Menyhart. Their work appears in journals such as Helvetica Chimica Acta, Cellular and Molecular Life Sciences, Molecular Pharmacology, Journal of Biological Chemistry and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.